Alkermes (ALKS) Common Equity (2010 - 2026)
Alkermes (ALKS) posted quarterly Common Equity of $1.8 billion for Q2 2026, up 11.32% year-over-year from $1.6 billion in Q2 2025, and up 3.26% quarter-over-quarter from $1.8 billion in Q1 2026.
Alkermes (ALKS) Common Equity (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Common Equity for 17 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 11.32% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (up 11.32% YoY), while the FY2025 annual figure was $1.8 billion, up 24.19% from the prior year.
- Common Equity rose to $1.8 billion in Q2 2026 per ALKS's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Common Equity topped out at $1.8 billion in Q4 2025 and bottomed at $1.0 billion in Q1 2023.
- Historically, Common Equity has averaged $1.4 billion across 5 years, with a median of $1.3 billion in 2024.
- Annual changes were most pronounced in 2023 — Common Equity retreated 6.49% — and 2025, when it soared 34.16%.
- Alkermes' Common Equity stood at $1.0 billion in 2022, then climbed by 15.23% to $1.2 billion in 2023, then advanced by 21.81% to $1.5 billion in 2024, then increased by 24.19% to $1.8 billion in 2025, then decreased by 0.59% to $1.8 billion in 2026.
- Business Quant data shows ALKS's Common Equity at $1.8 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Bn |
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.73 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.46 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 1.10 Bn |